Clinical Pharmacology Drug/Medication Reference Updated with Latest CDC Recommendations on Swine Influenza A (H1N1) Virus
Philadelphia, PA, 4 May 2009 - Elsevier, the leading publisher of scientific, technical and medical information, announced today that Dr. David Goldmann has joined Elsevier Health Sciences as Vice President, Editor-in-Chief, First Consult. As Editor-in-Chief, Dr. Goldmann is responsible for developing the overall content strategy and vision and leading the entire content production of First Consult and derivative products.
Michael Hansen, Chief Executive Officer, Elsevier Health Sciences said of the appointment, "David’s background and expertise will help Elsevier become an even stronger knowledge partner, anticipating clinicians’ needs across disciplines and providing accurate, timely, evidence-based answers to their questions."
First Consult is part of the Elsevier Health Sciences Clinical Decision Support group that serves the information needs of healthcare organizations and professionals across disciplines, including healthcare researchers, practitioners, providers and payors. First Consult is an authoritative evidence-based and regularly updated clinical information resource for healthcare professionals. Designed for use at the point of care, it provides instant, user-friendly access to the latest information on evaluation, diagnosis, clinical management, prognosis and prevention.
Dr. Goldmann brings a wealth of experience in the medical field. He is an internist and Associate Professor of Medicine at the University of Pennsylvania and has held a number of editorial positions at the American College of Physicians (ACP), where he was Editor-in-Chief of the Physicians’ Information and Education Resource (PIER), an evidence-based, electronic medical knowledge resource; Associate, Deputy and Senior Deputy Editor with the Journal Annals of Internal Medicine; and Consulting Editor to ACP Internist and the ACP Foundation HEALTH TiPS patient education program.
Dr. Goldmann was educated at Harvard College, Harvard Medical School and University of Sussex.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
+1 212 462 1912